ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.663,66
-0,33%
S&P 500
5.321,41
0,25%
Dow Jones
39.872,99
0,00%
Euro vs US Dollar
1,08274
-0,25%
Bitcoin
69.993,41
-0,20%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Eucrates Biomedical Acquisition Corporation (EUCR)

  7. Eucrates Biomedical Acquisition Corporation (EUCR) News

EUCR

Eucrates Biomedical Acqu... (EUCR)

Eucrates Biomedical Acquisition Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:EUCR
DatumZeitQuelleÜberschriftSymbolFirma
26/04/202322h53Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:EUCREucrates Biomedical Acquisition Corporation
11/04/202323h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EUCREucrates Biomedical Acquisition Corporation
11/04/202323h00PR Newswire (US)Eucrates Biomedical Acquisition Corp. Announces LiquidationNASDAQ:EUCREucrates Biomedical Acquisition Corporation
03/04/202322h19Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EUCREucrates Biomedical Acquisition Corporation
29/03/202322h41Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:EUCREucrates Biomedical Acquisition Corporation
16/02/202322h14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EUCREucrates Biomedical Acquisition Corporation
10/02/202315h44Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:EUCREucrates Biomedical Acquisition Corporation
14/11/202223h37Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EUCREucrates Biomedical Acquisition Corporation
08/11/202222h29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EUCREucrates Biomedical Acquisition Corporation
31/10/202221h20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EUCREucrates Biomedical Acquisition Corporation
05/10/202223h21Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:EUCREucrates Biomedical Acquisition Corporation
16/05/202222h50Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:EUCREucrates Biomedical Acquisition Corporation
11/04/202212h04Edgar (US Regulatory)Annual Report (10-k)NASDAQ:EUCREucrates Biomedical Acquisition Corporation
14/02/202220h43Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:EUCREucrates Biomedical Acquisition Corporation
08/02/202223h17Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:EUCREucrates Biomedical Acquisition Corporation
26/01/202222h16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EUCREucrates Biomedical Acquisition Corporation
20/12/202122h34Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:EUCREucrates Biomedical Acquisition Corporation
22/11/202122h33Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EUCREucrates Biomedical Acquisition Corporation
16/11/202112h05Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:EUCREucrates Biomedical Acquisition Corporation
16/08/202121h27Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EUCREucrates Biomedical Acquisition Corporation
16/07/202122h07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EUCREucrates Biomedical Acquisition Corporation
15/07/202123h29Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:EUCREucrates Biomedical Acquisition Corporation
21/06/202122h23Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EUCREucrates Biomedical Acquisition Corporation
01/06/202114h00PR Newswire (US)Eucrates Biomedical Acquisition Corp. Receives Expected Notice From Nasdaq Regarding Delayed Quarterly ReportNASDAQ:EUCREucrates Biomedical Acquisition Corporation
17/05/202113h33Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:EUCREucrates Biomedical Acquisition Corporation
31/03/202122h03Edgar (US Regulatory)Annual Report (10-k)NASDAQ:EUCREucrates Biomedical Acquisition Corporation
12/02/202122h04Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:EUCREucrates Biomedical Acquisition Corporation
08/02/202112h02Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:EUCREucrates Biomedical Acquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:EUCR

Kürzlich von Ihnen besucht

COIN
SHBTC
EU
INRP3
ISHARES CNYB INAV
FTSE
WIUAE
FTSE United Arab Emirates
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten